Difference between revisions of "Eluvixtamab (AMG-330)"
Jump to navigation
Jump to search
m |
m |
||
| Line 6: | Line 6: | ||
[[Category:Antibody medications]] | [[Category:Antibody medications]] | ||
| + | [[Category:BiTE antibodies]] | ||
| + | [[Category:Anti-CD33 antibodies]] | ||
| + | [[Category:Anti-CD3 antibodies]] | ||
[[Category:Investigational]] | [[Category:Investigational]] | ||
Revision as of 15:24, 26 November 2014
Mechanism of action
Bispecific T-cell engager (BiTE) antibody that engages CD33 and CD3